Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP in Tympanoplasty for Chronic Otitis Media
NCT07664319Completed
- Sponsor
- Ebubekir Toprak
- Start
- Apr 2023
- Primary completion
- Jun 2023
- Countries
- 1
01
Overview
Randomised, single-blind trial of autologous platelet-rich plasma in chronic otitis media (COM) and tympanic membrane perforation (2 arms), sponsored by Ebubekir Toprak. Primary endpoint: Graft integrity (intact tympanic membrane) at 2 months. Started Apr 2023; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
chronic otitis media (COM)tympanic membrane perforation
Beyond the preview
Go deeper on NCT07664319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07664319.